March 9 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] has recorded a consolidated net profit of 13.1 million euro ($14.7 million) in 2022, slightly up from 13 million euro in the previous year, it said on Thursday.